TMDX
HEALTHCARETransMedics Group Inc
AI Insight
What's Moving TMDX Today?
No stock-specific AI insight has been generated for TMDX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$60.10$156.00
$73.83
Fundamentals
Market Cap$2.6B
P/E Ratio16.9
EPS$4.37
Dividend Yield—
Dividend / Share—
ROE45.2%
Profit Margin27.0%
Debt / Equity—
Trading
Volume823K
Avg Volume (10D)—
Shares Outstanding34.6M
TMDX News
25 articles- Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative?Yahoo Finance·Jun 6, 2026
- TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?Yahoo Finance·Jun 4, 2026
- TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Hold" by BrokeragesMarketBeat·Jun 2, 2026
- Reasons to Retain TransMedics Stock in Your Portfolio for NowYahoo Finance·May 28, 2026
- Director at TransMedics (TMDX) receives 2,922 RSU equity grant, holds 5,788 sharesStock Titan·May 23, 2026
- TransMedics (NASDAQ: TMDX) investors approve directors, pay, stock plan and auditorStock Titan·May 22, 2026
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Yahoo Finance·May 21, 2026
- TransMedics to Present at the William Blair 46th Annual Growth Stock ConferenceYahoo Finance·May 19, 2026
- Assessing TransMedics Group (TMDX) Valuation After A Sharp One Year Share Price DeclineYahoo Finance·May 10, 2026
- TransMedics Group Inc (TMDX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...Yahoo Finance·May 8, 2026
- TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Moderate Buy" by BrokeragesMarketBeat·May 8, 2026
- Glucotrack Submits Blood Glucose Monitoring Technology to FDAYahoo Finance·May 7, 2026
- My Top 3 Stocks to Buy in MayMotley Fool·May 7, 2026
- TransMedics Group (NASDAQ:TMDX) Given New $124.00 Price Target at Canaccord Genuity GroupMarketBeat·May 7, 2026
- TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins FallYahoo Finance·May 6, 2026
- TransMedics (TMDX) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- AMD upgraded, Reddit downgraded: Wall Street's top analyst callsYahoo Finance·May 6, 2026
- TransMedics Group, Inc. Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- TransMedics Group Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- TransMedics (TMDX) Reports Q1 Earnings: What Key Metrics Have to SayYahoo Finance·May 5, 2026
- TransMedics (TMDX) Q1 Earnings and Revenues Miss EstimatesYahoo Finance·May 5, 2026
- TransMedics Reports First Quarter 2026 Financial ResultsYahoo Finance·May 5, 2026
- TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbHYahoo Finance·Apr 29, 2026
- TransMedics Unveils CHOPS As Trials Progress And Valuation Screens UndervaluedYahoo Finance·Apr 27, 2026
- Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now?Yahoo Finance·Apr 24, 2026
All 25 articles loaded
Price Data
Open$74.66
Previous Close$73.83
Day High$75.78
Day Low$72.79
52 Week High$156.00
52 Week Low$60.10
52-Week Range
$60.10$156.00
$73.83
Fundamentals
Market Cap$2.6B
P/E Ratio16.9
EPS$4.37
Dividend Yield—
Dividend / Share—
ROE45.2%
Profit Margin27.0%
Debt / Equity—
Trading
Volume823K
Avg Volume (10D)—
Shares Outstanding34.6M
About TransMedics Group Inc
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—